Condition: Graves Disease · Sponsor: Biohaven Therapeutics Ltd.
The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroid
This description comes directly from the study's public registry record.
Chief Medical Officer · 203-404-0410 · clinicaltrials@biohavenpharma.com
Always discuss trial participation with your own doctor first.
| Site-032 | Burbank, California, United States | Recruiting |
| Site-006 | San Diego, California, United States | Recruiting |
| Site-067 | Walnut Creek, California, United States | Recruiting |
| Site-052 | Doral, Florida, United States | Recruiting |
| Site-019 | Hialeah, Florida, United States | Recruiting |
| Site-031 | Champaign, Illinois, United States | Recruiting |
| Site-025 | Lenexa, Kansas, United States | Recruiting |
| Site-072 | Las Vegas, Nevada, United States | Recruiting |
| Site-038 | Asheville, North Carolina, United States | Recruiting |
| Site-064 | Morehead City, North Carolina, United States | Recruiting |
| Site-033 | Statesville, North Carolina, United States | Recruiting |
| Site-045 | Wilmington, North Carolina, United States | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07661056